We first spoke with Byron Hewett, the CEO of Cambridge, Mass.-based BioBehavioral Diagnostics Co., late last summer, following a $2.5 million funding round that saw the company sell convertible debt securities to a trio of investors.In the interim things changed for us and Hewett and BBDx. We upgraded our office computer and, in the process, [...]